All Stories

  1. In Memoriam: Robert Emmons Kissling (1923–2013)

    Article • Emerging Infectious Diseases, August 2014, Centers for Disease Control and Prevention (CDC)

    Dr Thomas P. Monath

  2. Coltiviruses

    Article • June 2014, Wiley

    Dr Thomas P. Monath

  3. A manifesto for planetary health

    Article • The Lancet, April 2014, Elsevier

    Dr Thomas P. Monath

  4. Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

    Article • Viruses, December 2013, MDPI AG

    Dr Thomas P. Monath, Dr Gustavo H Dayan

  5. 17D Yellow Fever Virus Vaccine

    Article • American Journal of Tropical Medicine and Hygiene, December 2013, American Society of Tropical Medicine and Hygiene

    Dr Thomas P. Monath

  6. Vaccines against diseases transmitted from animals to humans: A one health paradigm

    Article • Vaccine, November 2013, Elsevier

    Dr Thomas P. Monath

  7. Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus

    Article • Infection Genetics and Evolution, October 2013, Elsevier

    Dr Thomas P. Monath, Professor Nikos Vasilakis

  8. Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes

    Article • Virus Research, September 2013, Elsevier

    Dr Thomas P. Monath

  9. Yellow fever vaccine

    Article • January 2013, Elsevier

    Dr Thomas P. Monath

  10. Review of the risks and benefits of yellow fever vaccination including some new analyses

    Article • Expert Review of Vaccines, April 2012, Taylor & Francis

    Dr Thomas P. Monath

  11. Full Genomic Sequence of the Prototype Strain (M64) of Rio Bravo Virus

    Article • Journal of Virology, March 2012, ASM Journals

    Dr Thomas P. Monath

  12. Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice

    Article • Vaccine, January 2012, Elsevier

    Dr Thomas P. Monath

  13. Yellow Fever Vaccine Seroconversion in Travelers

    Article • American Journal of Tropical Medicine and Hygiene, October 2011, American Society of Tropical Medicine and Hygiene

    Dr Thomas P. Monath

  14. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model

    Article • Vaccine, August 2011, Elsevier

    Dr Thomas P. Monath

  15. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

    Article • The Lancet Infectious Diseases, August 2011, Elsevier

    Dr Thomas P. Monath

  16. Yellow fever

    Article • July 2011, Oxford University Press (OUP)

    Dr Thomas P. Monath

  17. An Inactivated Cell-Culture Vaccine against Yellow Fever

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2011, New England Journal of Medicine (NEJM/MMS)

    Dr Thomas P. Monath

  18. Development of Antigen-Specific Memory CD8+ T Cells Following Live-Attenuated Chimeric West Nile Virus Vaccination

    Article • The Journal of Infectious Diseases, January 2011, Oxford University Press (OUP)

    Dr Thomas P. Monath

  19. Yellow Fever

    Article • January 2011, Elsevier

    Dr Thomas P. Monath

  20. Yellow Fever Vaccines: The Success of Empiricism, Pitfalls of Application, and Transition to Molecular Vaccinology

    Article • January 2011, Springer Science + Business Media

    Dr Thomas P. Monath

  21. Classical Live Viral Vaccines

    Article • September 2010, Springer Science + Business Media

    Dr Thomas P. Monath

  22. Recombinant, Chimeric, Live, Attenuated Vaccines Against Flaviviruses and Alphaviruses

    Article • September 2010, Springer Science + Business Media

    Dr Thomas P. Monath

  23. Architectural options and challenges for next generation optical access

    Article • September 2010, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Thomas P. Monath

  24. A multi-actor analysis of the QoE environment

    Article • June 2010, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Thomas P. Monath

  25. Economical analysis of experience-optimized service delivery

    Article • June 2010, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Thomas P. Monath

  26. Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

    Article • Vaccine, May 2010, Elsevier

    Dr Thomas P. Monath

  27. Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States

    Article • American Journal of Tropical Medicine and Hygiene, May 2010, American Society of Tropical Medicine and Hygiene

    Dr Thomas P. Monath

  28. The Convergence of Human and Animal Medicine

    Article • January 2010, Elsevier

    Dr Thomas P. Monath

  29. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

    Article • Vaccine, January 2010, Elsevier

    Dr Thomas P. Monath

  30. One Health Perspective

    Article • ILAR Journal, January 2010, Oxford University Press (OUP)

    Dr Thomas P. Monath

  31. Yellow Fever

    Article • November 2009, Springer Science + Business Media

    Dr Thomas P. Monath

  32. Viscerotropic disease following yellow fever vaccination in Peru

    Article • Vaccine, October 2009, Elsevier

    Dr Thomas P. Monath, Dr Margo A Brinton

  33. Evaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization Tests

    Article • Clinical and Vaccine Immunology, May 2009, ASM Journals

    Dr Thomas P. Monath

  34. Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis

    Article • Vaccine, March 2009, Elsevier

    Dr Thomas P. Monath

  35. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults

    Article • Vaccine, March 2009, Elsevier

    Dr Thomas P. Monath

  36. Yellow Fever

    Article • January 2009, Elsevier

    Dr Thomas P. Monath

  37. 'ONE HEALTH' and parasitology

    Article • Parasites & Vectors, January 2009, Springer Science + Business Media

    Dr Thomas P. Monath

  38. 91. Stabilization of live biologicals at ambient temperatures using preservation by vaporization

    Article • Cryobiology, December 2008, Elsevier

    Dr Thomas P. Monath

  39. Use of a Surrogate Chimeric Virus To Detect West Nile Virus-Neutralizing Antibodies in Avian and Equine Sera

    Article • Clinical and Vaccine Immunology, November 2008, ASM Journals

    Dr Thomas P. Monath

  40. Safety of flavivirus chimeric vaccines: Answer to Ishikawa et al. [Vaccine 26 (22) (2008) 2772–2781]

    Article • Vaccine, August 2008, Elsevier

    Dr Thomas P. Monath

  41. Executive summary of the AVMA One Health Initiative Task Force report

    Article • Journal of the American Veterinary Medical Association, July 2008, American Veterinary Medical Association (AVMA)

    Dr Thomas P. Monath

  42. Treatment of yellow fever

    Article • Antiviral Research, April 2008, Elsevier

    Dr Thomas P. Monath, Johan Neyts

  43. Teaching “One Medicine, One Health”

    Article • The American Journal of Medicine, March 2008, Elsevier

    Dr Thomas P. Monath

  44. Improving vaccine coverage in Africa

    Article • The Lancet, February 2008, Elsevier

    Dr Thomas P. Monath, Dr Folorunso Oludayo FO Fasina

  45. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge

    Article • Vaccine, January 2008, Elsevier

    Dr Thomas P. Monath

  46. Dengue and Yellow Fever — Challenges for the Development and Use of Vaccines

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2007, New England Journal of Medicine (NEJM/MMS)

    Dr Thomas P. Monath

  47. Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences

    Article • Vaccine, November 2007, Elsevier

    Dr Thomas P. Monath

  48. Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE)

    Article • Vaccine, September 2007, Elsevier

    Dr Thomas P. Monath

  49. A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus

    Article • Virology, June 2007, Elsevier

    Dr Thomas P. Monath

  50. 17D yellow fever vaccines: New insights

    Article • Vaccine, April 2007, Elsevier

    Dr Thomas P. Monath, Professor Matthias Niedrig

  51. Viral vectors for malaria vaccine development

    Article • Vaccine, March 2007, Elsevier

    Dr Thomas P. Monath, Professor Peter Liljeström

  52. Coltiviruses

    Article • September 2006, Wiley

    Dr Thomas P. Monath

  53. Correction for Monath et al., A live, attenuated recombinant West Nile virus vaccine

    Article • Proceedings of the National Academy of Sciences, July 2006, Proceedings of the National Academy of Sciences

    Dr Thomas P. Monath

  54. A live, attenuated recombinant West Nile virus vaccine

    Article • Proceedings of the National Academy of Sciences, April 2006, Proceedings of the National Academy of Sciences

    Dr Thomas P. Monath

  55. Lack of Transmission of Vaccinia Virus

    Article • Emerging Infectious Diseases, April 2006, Centers for Disease Control and Prevention (CDC)

    Dr Thomas P. Monath

  56. Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

    Article • Human Vaccines, March 2006, Taylor & Francis

    Dr Thomas P. Monath

  57. Yellow Fever

    Article • January 2006, Elsevier

    Dr Thomas P. Monath

  58. Flow‐Cytometric Detection of Vaccinia‐Induced Memory Effector CD4 + , CD8 + , and γδTCR + T Cells Capable of Antigen‐Specific Expansion and Effector Functions

    Article • The Journal of Infectious Diseases, October 2005, Oxford University Press (OUP)

    Dr Thomas P. Monath

  59. New developments in flavivirus vaccines with special attention to yellow fever

    Article • Current Opinion in Infectious Diseases, October 2005, Wolters Kluwer Health

    Dr Thomas P. Monath

  60. Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly

    Article • Human Vaccines, September 2005, Taylor & Francis

    Dr Thomas P. Monath

  61. Interview with Thomas P. Monath, M.D.

    Article • Vector-Borne and Zoonotic Diseases, September 2005, Mary Ann Liebert Inc

    Dr Thomas P. Monath

  62. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: Infant mice provide an accurate surrogate for the test in monkeys

    Article • Biologicals, September 2005, Elsevier

    Dr Thomas P. Monath

  63. Yellow fever vaccine

    Article • Expert Review of Vaccines, August 2005, Taylor & Francis

    Dr Thomas P. Monath

  64. Yellow fever

    Article • Medicine, July 2005, Elsevier

    Dr Thomas P. Monath

  65. Virology Division News

    Article • Archives of Virology, June 2005, Springer Science + Business Media

    Dr Thomas P. Monath

  66. A novel, cell culture-derived smallpox vaccine in vaccinia-naïve adults

    Article • Vaccine, May 2005, Elsevier

    Dr Thomas P. Monath

  67. Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates

    Article • Human Vaccines, May 2005, Taylor & Francis

    Dr Thomas P. Monath

  68. Recombination and flavivirus vaccines: a commentary

    Article • Vaccine, April 2005, Elsevier

    Dr Thomas P. Monath, Dr Margo A Brinton

  69. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

    Article • Gastroenterology, March 2005, Elsevier

    Dr Thomas P. Monath

  70. Exercise-Induced Serum Enzyme Elevations Confounding the Evaluation of Investigational Drug Toxicity: Report of Two Cases in a Vaccine Trial

    Article • Human Vaccines, January 2005, Taylor & Francis

    Dr Thomas P. Monath

  71. ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy

    Article • Journal of Virology, November 2004, ASM Journals

    Dr Thomas P. Monath

  72. New Concepts for Vaccines1

    Article • Emerging Infectious Diseases, November 2004, Centers for Disease Control and Prevention (CDC)

    Dr Thomas P. Monath

  73. Specific Immunoglobulin A Antibodies in Maternal Milk and Delayed Helicobacter pylori Colonization in Gambian Infants

    Article • Clinical Infectious Diseases, October 2004, Oxford University Press (OUP)

    Dr Thomas P. Monath

  74. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense

    Article • International Journal of Infectious Diseases, October 2004, Elsevier

    Dr Thomas P. Monath

  75. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense

    Article • International Journal of Infectious Diseases, October 2004, Elsevier

    Dr Thomas P. Monath

  76. A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys

    Article • Journal of Virology, September 2004, ASM Journals

    Dr Thomas P. Monath

  77. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

    Article • Vaccine, September 2004, Elsevier

    Dr Thomas P. Monath

  78. Chimeric Vaccines Against Japanese Encephalitis, Dengue, and West Nile

    Article • January 2004, Taylor & Francis

    Dr Thomas P. Monath

  79. High Fidelity of Yellow Fever Virus RNA Polymerase

    Article • Journal of Virology, January 2004, ASM Journals

    Dr Thomas P. Monath

  80. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection

    Article • The American Journal of Gastroenterology, November 2003, Wolters Kluwer Health

    Dr Thomas P. Monath

  81. Helicobacter pylori Reinfection Is Common in Peruvian Adults after Antibiotic Eradication Therapy

    Article • The Journal of Infectious Diseases, November 2003, Oxford University Press (OUP)

    Dr Thomas P. Monath

  82. Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

    Article • The Journal of Infectious Diseases, October 2003, Oxford University Press (OUP)

    Dr Thomas P. Monath

  83. Growth characteristics of the veterinary vaccine candidate ChimeriVax™‐West Nile (WN) virus in Aedes and Culex mosquitoes

    Article • Medical and Veterinary Entomology, August 2003, Wiley

    Dr Thomas P. Monath

  84. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine

    Article • Nature Medicine, August 2003, Springer Science + Business Media

    Dr Thomas P. Monath

  85. THOMAS MONATH PROFILE: Riding the Biodefense Wave

    Article • Science, August 2003, American Association for the Advancement of Science

    Dr Thomas P. Monath

  86. Development of a Novel Vaccinia‐Neutralization Assay Based on Reporter‐Gene Expression

    Article • The Journal of Infectious Diseases, August 2003, Oxford University Press (OUP)

    Dr Thomas P. Monath

  87. Traditional and novel approaches to flavivirus vaccines

    Article • International Journal for Parasitology, May 2003, Elsevier

    Dr Thomas P. Monath

  88. Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A

    Article • Infection and Immunity, March 2003, ASM Journals

    Dr Thomas P. Monath

  89. Coltiviruses

    Article • January 2003, Wiley

    Dr Thomas P. Monath

  90. Pathogenesis and Pathophysiology of Yellow Fever

    Article • January 2003, Elsevier

    Dr Thomas P. Monath

  91. Epidemiology and ecology of yellow fever virus

    Article • January 2003, Elsevier

    Dr Thomas P. Monath

  92. Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis

    Article • January 2003, Elsevier

    Dr Thomas P. Monath

  93. Safety and efficacy of E. coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori

    Article • Vaccine, December 2002, Elsevier

    Dr Thomas P. Monath

  94. Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model

    Article • Emerging Infectious Diseases, December 2002, Centers for Disease Control and Prevention (CDC)

    Dr Thomas P. Monath

  95. Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen

    Article • Infection and Immunity, September 2002, ASM Journals

    Dr Thomas P. Monath

  96. Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates

    Article • Virology, June 2002, Elsevier

    Dr Thomas P. Monath

  97. Prevention of Yellow Fever in Persons Traveling to the Tropics

    Article • Clinical Infectious Diseases, May 2002, Oxford University Press (OUP)

    Dr Thomas P. Monath

  98. Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines

    Article • Journal of Virology, February 2002, ASM Journals

    Dr Thomas P. Monath

  99. Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

    Article • Vaccine, January 2002, Elsevier

    Dr Thomas P. Monath

  100. Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

    Article • Vaccine, January 2002, Elsevier

    Dr Thomas P. Monath

  101. Japanese Encephalitis Vaccines: Current Vaccines and Future Prospects

    Article • January 2002, Springer Science + Business Media

    Dr Thomas P. Monath

  102. Prospects for Development of a Vaccine against the West Nile Virus

    Article • Annals of the New York Academy of Sciences, December 2001, Wiley

    Dr Thomas P. Monath

  103. Phenotypic and Molecular Analyses of Yellow Fever 17DD Vaccine Viruses Associated with Serious Adverse Events in Brazil

    Article • Virology, November 2001, Elsevier

    Dr Thomas P. Monath

  104. Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent

    Article • Vaccine, September 2001, Elsevier

    Dr Thomas P. Monath

  105. Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

    Article • Journal of Virology, August 2001, ASM Journals

    Dr Thomas P. Monath

  106. Yellow fever: an update

    Article • The Lancet Infectious Diseases, August 2001, Elsevier

    Dr Thomas P. Monath

  107. Yellow fever vector live-virus vaccines: West Nile virus vaccine development

    Article • Trends in Molecular Medicine, August 2001, Elsevier

    Dr Thomas P. Monath

  108. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

    Article • The Lancet, July 2001, Elsevier

    Dr Thomas P. Monath, Dr Expedito J Luna

  109. Posttreatment Follow-Up of Helicobacter pylori Infection Using a Stool Antigen Immunoassay

    Article • Clinical and Diagnostic Laboratory Immunology, July 2001, ASM Journals

    Dr Thomas P. Monath

  110. Yellow Fever

    Article • Medicine, May 2001, Elsevier

    Dr Thomas P. Monath

  111. West Nile Virus Vaccine.

    Article • Current Drug Targets - Infectious Disorders, May 2001, Bentham Science Publishers

    Dr Thomas P. Monath

  112. Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice Optimal prophylactic combinations are different from therapeutic ones

    Article • FEMS Immunology & Medical Microbiology, March 2001, Oxford University Press (OUP)

    Dr Thomas P. Monath

  113. Safety and Immunogenicity of Increasing Doses of aClostridium difficile Toxoid Vaccine Administered to Healthy Adults

    Article • Infection and Immunity, February 2001, ASM Journals

    Dr Thomas P. Monath

  114. Molecular Basis for Attenuation of Neurovirulence of a Yellow Fever Virus/Japanese Encephalitis Virus Chimera Vaccine (ChimeriVax-JE)

    Article • Journal of Virology, January 2001, ASM Journals

    Dr Thomas P. Monath

  115. Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates

    Article • Journal of Virology, June 2000, ASM Journals

    Dr Thomas P. Monath

  116. Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pyloriInfection

    Article • Infection and Immunity, May 2000, ASM Journals

    Dr Thomas P. Monath

  117. Low dose E. coli enterotoxin for urease-based oral immunization against H. pylori in healthy volunteers: Can it be safe and effective

    Article • Gastroenterology, April 2000, Elsevier

    Dr Thomas P. Monath

  118. Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys

    Article • Journal of Virology, February 2000, ASM Journals

    Dr Thomas P. Monath

  119. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori

    Article • Vaccine, August 1999, Elsevier

    Dr Thomas P. Monath

  120. Facing up to re-emergence of urban yellow fe ver

    Article • The Lancet, May 1999, Elsevier

    Dr Thomas P. Monath

  121. Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis

    Article • Virology, May 1999, Elsevier

    Dr Thomas P. Monath

  122. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-huma...

    Article • Vaccine, April 1999, Elsevier

    Dr Thomas P. Monath

  123. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

    Article • Gastroenterology, April 1999, Elsevier

    Dr Thomas P. Monath

  124. Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus

    Article • Protein Engineering Design and Selection, April 1999, Oxford University Press (OUP)

    Dr Thomas P. Monath

  125. Ecology of Marburg and Ebola Viruses: Speculations and Directions for Future Research

    Article • The Journal of Infectious Diseases, February 1999, Oxford University Press (OUP)

    Dr Thomas P. Monath

  126. Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses

    Article • Journal of Experimental Medicine, December 1998, Rockefeller University Press

    Dr Thomas P. Monath

  127. Does Restricted Distribution Limit Access and Coverage of Yellow Fever Vaccine in the United States?

    Article • December 1998, Centers for Disease Control and Prevention (CDC)

    Dr Thomas P. Monath

  128. BIOLOGICAL WARFARE:Strengthening the Biological Weapons Convention

    Article • November 1998, American Association for the Advancement of Science

    Dr Thomas P. Monath

  129. Specific anti-H. pyloriurease IgA in human Breastmilk and delayedH. pyloricolonisation in Gambian infants.

    Article • Journal of Pediatric Gastroenterology and Nutrition, May 1998, Wiley

    Dr Thomas P. Monath

  130. Vaccine development against infection with Helicobacter pylori

    Article • British Medical Bulletin, January 1998, Oxford University Press (OUP)

    Dr Thomas P. Monath

  131. Early indicators in acute dengue infection

    Article • The Lancet, December 1997, Elsevier

    Dr Thomas P. Monath

  132. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting

    Article • Vaccine, October 1997, Elsevier

    Dr Thomas P. Monath

  133. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria

    Article • Gastroenterology, October 1997, Elsevier

    Dr Thomas P. Monath

  134. Physicians identify Clostridium difficile colitis as a serious problem in need of new immune therapies

    Article • Gastrointestinal Endoscopy, April 1997, Elsevier

    Dr Thomas P. Monath

  135. Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus

    Article • Immunotechnology, September 1996, Elsevier

    Dr Thomas P. Monath

  136. Immunogenicity and safety of recombinantHelicobacter pylori urease in a nonhuman primate

    Article • Digestive Diseases and Sciences, September 1996, Springer Science + Business Media

    Dr Thomas P. Monath

  137. Intranasal Monoclonal IgA Antibody to Respiratory Syncytial Virus Protects Rhesus Monkeys against Upper and Lower Respiratory Tract Infection

    Article • The Journal of Infectious Diseases, August 1996, Oxford University Press (OUP)

    Dr Thomas P. Monath

  138. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets

    Article • Gastroenterology, June 1996, Elsevier

    Dr Thomas P. Monath

  139. Antigenicity of amino-acid sequences from Clostridium difficile toxin B

    Article • Journal of Medical Microbiology, June 1996, Society for General Microbiology

    Dr Thomas P. Monath

  140. Oral Immunization with Recombinant Helicobacter pylori Urease Induces Secretory IgA Antibodies and Protects Mice from Challenge with Helicobacter felis

    Article • The Journal of Infectious Diseases, July 1995, Oxford University Press (OUP)

    Dr Thomas P. Monath

  141. Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles

    Article • Archives of Virology, May 1995, Springer Science + Business Media

    Dr Thomas P. Monath

  142. Specific amplification by PCR of rearranged genomic variable regions of immunoglobulin genes from mouse hybridoma cells.

    Article • Genome Research, April 1995, Cold Spring Harbor Laboratory Press

    Dr Thomas P. Monath

  143. Prophylactic therapy of respiratory syncytial virus (RSV) infection of rhesus monkeys with monoclonal IgA antibody to RSV

    Article • Antiviral Research, March 1995, Elsevier

    Dr Thomas P. Monath

  144. Vector‐borne Emergent Disease

    Article • Annals of the New York Academy of Sciences, December 1994, Wiley

    Dr Thomas P. Monath

  145. Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

    Article • Antimicrobial Agents and Chemotherapy, December 1994, ASM Journals

    Dr Thomas P. Monath

  146. Yellow fever and dengue—the interactions of virus, vector and host in the re-emergence of epidemic disease

    Article • Seminars in Virology, April 1994, Elsevier

    Dr Thomas P. Monath

  147. Dengue: the risk to developed and developing countries.

    Article • Proceedings of the National Academy of Sciences, March 1994, Proceedings of the National Academy of Sciences

    Dr Thomas P. Monath

  148. Analysis of a Yellow Fever Virus Isolated from a Fatal Case of Vaccine-Associated Human Encephalitis

    Article • The Journal of Infectious Diseases, March 1994, Oxford University Press (OUP)

    Dr Thomas P. Monath

  149. Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments

    Article • Journal of General Virology, February 1994, Society for General Microbiology

    Dr Thomas P. Monath

  150. Yellow fever vaccination and pregnancy: a four-year prospective study

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, May 1993, Oxford University Press (OUP)

    Dr Thomas P. Monath

  151. Antiviral (RNA) Activity of Selected Amaryllidaceae Isoquinoline Constituents and Synthesis of Related Substances

    Article • Journal of Natural Products, November 1992, American Chemical Society (ACS)

    Dr Thomas P. Monath

  152. Synthesis and antiviral evaluation of N-carboxamidine-substituted analogs of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride.

    Article • Journal of Medicinal Chemistry, August 1992, American Chemical Society (ACS)

    Dr Thomas P. Monath

  153. Obituary Joel McKeith Dalrymple (1939–1992)

    Article • Archives of Virology, March 1992, Springer Science + Business Media

    Dr Thomas P. Monath

  154. The Challenge: Biotechnology Transfer to Public Health. Examples from Arbovirology

    Article • January 1992, Springer Science + Business Media

    Dr Thomas P. Monath

  155. Activity of Selected Amaryllidaceae Constituents and Related Synthetic Substances Against Medically Important RNA Viruses

    Article • January 1992, Springer Science + Business Media

    Dr Thomas P. Monath

  156. Antiviral (RNA) evaluation of a series of substituted tyrosines

    Article • Antiviral Research, April 1991, Elsevier

    Dr Thomas P. Monath

  157. Ebola infected SCID mice as a model for drug evaluation

    Article • Antiviral Research, April 1991, Elsevier

    Dr Thomas P. Monath

  158. Inhibition of ebola virus replication in vitro and in a SCID mouse model by S-adenosylhomocysteine hydrolase inhibitors

    Article • Antiviral Research, April 1991, Elsevier

    Dr Thomas P. Monath

  159. Ribavirin, interferon, and antibody approaches to prophylaxis and therapy for viral hemorrhagic fevers

    Article • Current Opinion in Infectious Diseases, December 1990, Wolters Kluwer Health

    Dr Thomas P. Monath

  160. Imported Lassa Fever — Reexamining the Algorithms

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 1990, New England Journal of Medicine (NEJM/MMS)

    Dr Thomas P. Monath

  161. Attenuation of wild-type yellow fever virus by passage in HeLa cells

    Article • Journal of General Virology, October 1990, Society for General Microbiology

    Dr Thomas P. Monath

  162. Evaluation of the Potency and Safety of Inactivated Japanese Encephalitis Vaccine in US Inhabitants

    Article • The Journal of Infectious Diseases, May 1990, Oxford University Press (OUP)

    Dr Thomas P. Monath

  163. The Molecular Epidemiology of Dengue Viruses

    Article • January 1990, Springer Science + Business Media

    Dr Thomas P. Monath

  164. Potential for Insect Transmission of HIV: Experimental Exposure of Cimex hemipterus and Toxorhynchites amboinensis to Human Immunodeficiency Virus

    Article • The Journal of Infectious Diseases, December 1989, Oxford University Press (OUP)

    Dr Thomas P. Monath

  165. Genetic variation and microevolution of dengue 2 virus in Southeast Asia

    Article • Virology, October 1989, Elsevier

    Dr Thomas P. Monath

  166. Urban yellow fever epidemic in western Nigeria, 1987

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, May 1989, Oxford University Press (OUP)

    Dr Thomas P. Monath

  167. Japanese Encephalitis — A Plague of the Orient

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 1988, New England Journal of Medicine (NEJM/MMS)

    Dr Thomas P. Monath

  168. Dengue 2 Virus Envelope Protein Expressed by a Recombinant Vaccinia Virus Fails to Protect Monkeys against Dengue

    Article • Journal of General Virology, August 1988, Society for General Microbiology

    Dr Thomas P. Monath

  169. "YELLOWFEVER" IN EASTERN NIGERIA

    Article • The Lancet, July 1988, Elsevier

    Dr Thomas P. Monath

  170. EPIDEMIC YELLOW FEVER IN EASTERN NIGERIA, 1986

    Article • The Lancet, March 1988, Elsevier

    Dr Thomas P. Monath

  171. Togaviridae and Flaviviridae: The Alphavirases and Flaviviruses

    Article • January 1988, Springer Science + Business Media

    Dr Thomas P. Monath

  172. EPIZOOTIC VESICULAR STOMATITIS IN COLORADO, 1982: SOME OBSERVATIONS ON THE POSSIBLE ROLE OF WILDLIFE POPULATIONS IN AN ENZOOTIC MAINTENANCE CYCLE

    Article • Journal of Wildlife Diseases, April 1987, Wildlife Disease Association

    Dr Thomas P. Monath

  173. Lassa Fever--New Issues Raised by Field Studies in West Africa

    Article • The Journal of Infectious Diseases, March 1987, Oxford University Press (OUP)

    Dr Thomas P. Monath

  174. Type B hepatitis and yellow fever infections in West Africa

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1987, Oxford University Press (OUP)

    Dr Thomas P. Monath

  175. Yellow Fever: A Medically Neglected Disease. Report on a Seminar

    Article • Clinical Infectious Diseases, January 1987, Oxford University Press (OUP)

    Dr Thomas P. Monath

  176. Genetic and Epidemiological Studies of Dengue Type 2 Viruses by Hybridization Using Synthetic Deoxyoligonucleotides as Probes

    Article • Journal of General Virology, December 1986, Society for General Microbiology

    Dr Thomas P. Monath

  177. Geographic classification of dengue-2 virus strains by antigen signature analysis

    Article • Virology, October 1986, Elsevier

    Dr Thomas P. Monath

  178. Aedes albopictus, an Exotic Mosquito Vector in the United States

    Article • Annals of Internal Medicine, September 1986, American College of Physicians

    Dr Thomas P. Monath

  179. Multisite Monoclonal Immunoassay for Dengue Viruses: Detection of Viraemic Human Sera and Interference by Heterologous Antibody

    Article • Journal of General Virology, April 1986, Society for General Microbiology

    Dr Thomas P. Monath

  180. Pathobiology of the Flaviviruses

    Article • January 1986, Springer Science + Business Media

    Dr Thomas P. Monath

  181. Genetic Heterogeneity of Yellow Fever Virus Strains from Africa and the Americas

    Article • Journal of General Virology, January 1986, Society for General Microbiology

    Dr Thomas P. Monath

  182. Intérêt du titrage par elisa des IgM spécifiques pour le diagnostic et la surveillance de la circulation selvatique des flavivirus en afrique

    Article • Annales de lʼInstitut Pasteur Virologie, January 1986, Elsevier

    Dr Thomas P. Monath

  183. LeDantec Virus: Identification as a Rhabdovirus Associated with Human Infection and Formation of a New Serogroup

    Article • Journal of General Virology, December 1985, Society for General Microbiology

    Dr Thomas P. Monath

  184. Comparaison de différentes techniquespour la détection du virus de la fièvre jaune dans les prélèvements humains et les lots de moustiques: Intérêt d'une méthode rapide de diagnostic par ELISA

    Article • Annales de lʼInstitut Pasteur Virologie, April 1985, Elsevier

    Dr Thomas P. Monath

  185. Sindbis virus isolations from Saudi Arabian mosquitoes

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1985, Oxford University Press (OUP)

    Dr Thomas P. Monath

  186. Impact of Arthropod-Borne Virus Diseases on Africa and the Middle East

    Article • January 1984, Elsevier

    Dr Thomas P. Monath

  187. Genetic variation among dengue 2 viruses of different geographic origin

    Article • Virology, July 1983, Elsevier

    Dr Thomas P. Monath

  188. Ontogeny of Yellow Fever 17D Vaccine: RNA Oligonucleotide Fingerprint and Monoclonal Antibody Analyses of Vaccines Produced World-wide

    Article • Journal of General Virology, March 1983, Society for General Microbiology

    Dr Thomas P. Monath

  189. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein

    Article • Virology, February 1983, Elsevier

    Dr Thomas P. Monath

  190. From the Centers for Disease Control

    Article • The Journal of Infectious Diseases, February 1982, Oxford University Press (OUP)

    Dr Thomas P. Monath

  191. Genetic heterogeneity among Saint Louis encephalitis virus isolates of different geographic origin

    Article • Virology, October 1981, Elsevier

    Dr Thomas P. Monath

  192. Indirect fluorescent antibody test for the diagnosis of yellow fever

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1981, Oxford University Press (OUP)

    Dr Thomas P. Monath

  193. VARIATION AMONG STRAINS OF ST. LOUIS ENCEPHALITIS VIRUS: BASIS FOR A GENETIC, PATHOGENETIC, AND EPIDEMIOLOGIC CLASSIFICATION

    Article • Annals of the New York Academy of Sciences, November 1980, Wiley

    Dr Thomas P. Monath

  194. Studies of glucose metabolism in rhesus monkeys after venezuelan equine encephalitis virus infection

    Article • Journal of Medical Virology, January 1980, Wiley

    Dr Thomas P. Monath

  195. Viruses isolated from reptiles: Identification of three new members of the familyRhabdoviridae

    Article • Archives of Virology, March 1979, Springer Science + Business Media

    Dr Thomas P. Monath

  196. Necrotizing Myocarditis in Mice Infected with Western Equine Encephalitis Virus: Clinical, Electrocardiographic, and Histopathologic Correlations

    Article • The Journal of Infectious Diseases, July 1978, Oxford University Press (OUP)

    Dr Thomas P. Monath

  197. St. Louis Encephalitis in Memphis-Shelby County, Tennessee, 1975

    Article • Southern Medical Journal, June 1978, Southern Medical Association

    Dr Thomas P. Monath

  198. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1977, Oxford University Press (OUP)

    Dr Thomas P. Monath

  199. Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone

    Article • Science, July 1974, American Association for the Advancement of Science

    Dr Thomas P. Monath

  200. Experimental Studies of Rhesus Monkeys Infected with Epizootic and Enzootic Subtypes of Venezuelan Equine Encephalitis Virus

    Article • The Journal of Infectious Diseases, February 1974, Oxford University Press (OUP)

    Dr Thomas P. Monath

  201. Arbovirus studies in nupeko forest, a possible natural focus of yellow fever virus in Nigeria II. Entomological investigations and viruses isolated

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1974, Oxford University Press (OUP)

    Dr Thomas P. Monath

  202. Bwamba virus infection: A sero-survey of veterbrates in five ecological zones in Nigeria

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1974, Oxford University Press (OUP)

    Dr Thomas P. Monath

  203. Arbovirus studies in nupeko forest, a possible natural focus of yellow fever virus in Nigeria I. Description of the area and serological survey of humans and other vertebrate hosts

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1974, Oxford University Press (OUP)

    Dr Thomas P. Monath

  204. Lassa fever in Britain: an imported case.

    Article • BMJ, September 1973, BMJ

    Dr Thomas P. Monath

  205. Characterization of viruses (Witwatersrand and Germiston) isolated from mosquitoes and rodents collected near Lunyo Forest, Uganda, in 1968

    Article • Archives of Virology, June 1972, Springer Science + Business Media

    Dr Thomas P. Monath

  206. Effects of Thorotrast on Humoral Antibody, Viral Multiplication, and Interferon during Infection with St. Louis Encephalitis Virus in Mice

    Article • The Journal of Infectious Diseases, March 1971, Oxford University Press (OUP)

    Dr Thomas P. Monath